Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
已完结10由 大三 发布于 2026/11/1 19:59:30
DOI:10.1016/s0140-6736(25)01576-4
作者:Linda Stein Gold, April W Armstrong, Robert Bissonnette, Nina Magnolo, Ronald B Vender, Michael Sebastian, Maria Laura Galimberti, Athanasios Tsianakas, Marcelo Arnone, Paul Wallace, Margrit Simon, Jo
文献类型:期刊论文
补充材料:只需要正文